3284 results for «2026年3月23日300477股票行情»
3284 results
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
TAVI failure - Mechanisms and management
19 Nov 2023 – From PCR London Valves 2023
Explore various cases that focus on TAVI failure, including the effects of the mechanism of TAVR failure on outcomes after re-intervention, the prognostic impact of patient-prosthesis mismatch and paravalvular leak following TAVI, issues related to bioprosthetic valve dysfunction and much more!
Contemporary surgical and transcatheter approaches for multivalve disease
21 Nov 2023 – From PCR London Valves 2023
Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session: gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...
Key questions in mitral valve intervention - Transcatheter edge-to-edge repair (Part 1) - what do I need to know to do the procedure safely?
19 Nov 2023 – From PCR London Valves 2023
Analyze in depth the case of a 64-year-old female patient with ischaemic cardiomyopathy with LVEF 40 % and severe ventricular mitral regurgitation, who previously had NSTE-ACS treated with LAD and circumflex PCI, and who presented with recent worsening heart failure and persistent NYHA class II-III, and...
Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore the complexities of aortic valve disorders in this PCR Imaging Valves Madrid 2024 session, covering topics from grading challenges to intervention decisions in both asymptomatic and symptomatic patients, and learn more about advanced imaging techniques for quantifying aortic regurgitation severity and navigating treatment choices for...
The aortic regurgitation problem: an imaging and practical perspective
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...
Optimizing case selection and procedure guidance in transcatheter mitral valve interventions
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...
PCR Tokyo Valves 2024 Welcome Ceremony
17 Feb 2024 – From PCR Tokyo Valves 2024
After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
Advanced imaging strategies in transcatheter tricuspid valve therapies
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
Multivalvular disease: mitral and aortic valve challenges explored
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore cutting-edge transcatheter valve interventions for mitral and aortic valve disorders, including valve-in-valve procedures and management strategies for paravalvular leakages, and learn about diagnosing and treating mitral annular calcification and transcatheter options in infective endocarditis.
Primary mitral regurgitation edge to edge repair with one device - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.
LIVE case from Sendai Kousei Hospital - Sendai, Japan
Navigate the video by moving your mouse over the chapter icon in...
Late-Breaking Trial session
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...
Shaping the future of structural heart disease intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.
Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...
New possibilities in TEER
18 Feb 2024 – From PCR Tokyo Valves 2024
Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...
Learn the procedure strategy - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Medtronic focuses on learning what characteristic valves should be used to treat aortic stenosis patients with low calcification or with extremely small native aortic annuluses, and what to pay attention to during the procedure.
